These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. Rebouillat D; Hovanessian AG J Interferon Cytokine Res; 1999 Apr; 19(4):295-308. PubMed ID: 10334380 [TBL] [Abstract][Full Text] [Related]
3. The expression of both domains of the 69/71 kDa 2',5' oligoadenylate synthetase generates a catalytically active enzyme and mediates an anti-viral response. Marié I; Rebouillat D; Hovanessian AG Eur J Biochem; 1999 May; 262(1):155-65. PubMed ID: 10231377 [TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and characterization of two related and interferon-induced 56-kDa and 30-kDa proteins highly similar to 2'-5' oligoadenylate synthetase. Rebouillat D; Marié I; Hovanessian AG Eur J Biochem; 1998 Oct; 257(2):319-30. PubMed ID: 9826176 [TBL] [Abstract][Full Text] [Related]
5. The 100-kDa 2',5'-oligoadenylate synthetase catalyzing preferentially the synthesis of dimeric pppA2'p5'A molecules is composed of three homologous domains. Rebouillat D; Hovnanian A; Marié I; Hovanessian AG J Biol Chem; 1999 Jan; 274(3):1557-65. PubMed ID: 9880533 [TBL] [Abstract][Full Text] [Related]
6. Ap3A and Ap4A are primers for oligoadenylate synthesis catalyzed by interferon-inducible 2-5A synthetase. Turpaev K; Hartmann R; Kisselev L; Justesen J FEBS Lett; 1997 May; 408(2):177-81. PubMed ID: 9187362 [TBL] [Abstract][Full Text] [Related]
7. The human 2'-5'oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation. Hovanessian AG; Justesen J Biochimie; 2007; 89(6-7):779-88. PubMed ID: 17408844 [TBL] [Abstract][Full Text] [Related]
8. Interruption of myogenesis by transforming growth factor beta 1 or EGTA inhibits expression and activity of the myogenic-associated (2'-5') oligoadenylate synthetase and PKR. Salzberg S; Mandelboim M; Zalcberg M; Shainberg A Exp Cell Res; 1995 Jul; 219(1):223-32. PubMed ID: 7628537 [TBL] [Abstract][Full Text] [Related]
9. Lack of 2',5'-oligoadenylate-dependent RNase expression in the human hepatoma cell line HepG2. Tnani M; Bayard BA Biochim Biophys Acta; 1998 Mar; 1402(2):139-50. PubMed ID: 9561800 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the gene encoding the 100-kDa form of human 2',5' oligoadenylate synthetase. Rebouillat D; Hovnanian A; David G; Hovanessian AG; Williams BR Genomics; 2000 Dec; 70(2):232-40. PubMed ID: 11112351 [TBL] [Abstract][Full Text] [Related]
11. [The dynamics of 2',5'-oligoadenylate synthetase activity in the nuclear and cytoplasmic fractions of human fibroblasts treated by double-stranded RNAs, by their complexes with DEAE-dextran and by type-I recombinant interferons. The ratio of double-stranded RNA-activated and -nonactivated froms of the enzyme]. Sokolova TM; Antonov AIu; Makhov AM Antibiot Khimioter; 1991 Jun; 36(6):31-5. PubMed ID: 1898186 [TBL] [Abstract][Full Text] [Related]
12. Interferon action: binding of viral RNA to the 40-kilodalton 2'-5'-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. Gribaudo G; Lembo D; Cavallo G; Landolfo S; Lengyel P J Virol; 1991 Apr; 65(4):1748-57. PubMed ID: 1705989 [TBL] [Abstract][Full Text] [Related]
13. 2',5'-oligoadenylate synthetase from a lower invertebrate, the marine sponge Geodia cydonium, does not need dsRNA for its enzymatic activity. Lopp A; Kuusksalu A; Reintamm T; Müller WE; Kelve M Biochim Biophys Acta; 2002 Jun; 1590(1-3):140-9. PubMed ID: 12063177 [TBL] [Abstract][Full Text] [Related]
14. Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2',5'-oligoadenylate synthetases. Hovanessian AG J Interferon Res; 1991 Aug; 11(4):199-205. PubMed ID: 1717615 [TBL] [Abstract][Full Text] [Related]
15. Four different forms of interferon-induced 2',5'-oligo(A) synthetase identified by immunoblotting in human cells. Chebath J; Benech P; Hovanessian A; Galabru J; Revel M J Biol Chem; 1987 Mar; 262(8):3852-7. PubMed ID: 2434505 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of pppA(2'p5'A)n2'p5'AOH synthesis in extracts of interferon-treated HeLa cells. Minks MA; Benvin S; Baglioni C J Biol Chem; 1980 Jun; 255(11):5031-5. PubMed ID: 6154699 [TBL] [Abstract][Full Text] [Related]
17. Absence of the 40-kDa form of (2'-5')oligoadenylate synthetase and its corresponding mRNA from skin fibroblasts derived from Alzheimer disease patients. Khanna KK; An SJ; Wu JM; Landolfo S; Hovanessian AG Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5852-6. PubMed ID: 1712108 [TBL] [Abstract][Full Text] [Related]
18. Characterization of 69- and 100-kDa forms of 2-5A-synthetase from interferon-treated human cells. Hovanessian AG; Svab J; Marié I; Robert N; Chamaret S; Laurent AG J Biol Chem; 1988 Apr; 263(10):4945-9. PubMed ID: 3350819 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of interferon action. Effect of double-stranded RNA and the 5'-O-monophosphate form of 2',5'-oligoadenylate on the inhibition of reovirus mRNA translation in vitro. Miyamoto NG; Jacobs BL; Samuel CE J Biol Chem; 1983 Dec; 258(24):15232-7. PubMed ID: 6197414 [TBL] [Abstract][Full Text] [Related]